139 related articles for article (PubMed ID: 6086518)
1. Dilation of forearm blood vessels after angiotensin-converting-enzyme inhibition by captopril in hypertensive patients.
Johns DW; Ayers CR; Williams SC
Hypertension; 1984; 6(4):545-50. PubMed ID: 6086518
[TBL] [Abstract][Full Text] [Related]
2. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
[TBL] [Abstract][Full Text] [Related]
3. Effect of captopril (SQ 14225) on blood pressure, plasma renin activity and angiotensin I converting enzyme activity.
Larochelle P; Genest J; Kuchel O; Boucher R; Gutkowska Y; McKinstry D
Can Med Assoc J; 1979 Aug; 121(3):309-16. PubMed ID: 223756
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure.
Awan NA; Evenson MK; Needham KE; Win A; Mason DT
Am Heart J; 1981 Jan; 101(1):22-31. PubMed ID: 6257100
[TBL] [Abstract][Full Text] [Related]
5. Immediate regional blood flow distribution following angiotensin converting enzyme inhibition in patients with essential hypertension.
Ventura HO; Frohlich ED; Messerli FH; Kobrin I; Kardon MB
Am J Med; 1984 May; 76(5B):58-61. PubMed ID: 6328985
[TBL] [Abstract][Full Text] [Related]
6. Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captopril.
Waeber B; Brunner HR; Brunner DB; Curtet AL; Turini GA; Gavras H
Hypertension; 1980; 2(2):236-42. PubMed ID: 6247269
[TBL] [Abstract][Full Text] [Related]
7. Effect of captopril and enalapril on endothelial function in hypertensive patients.
Creager MA; Roddy MA
Hypertension; 1994 Oct; 24(4):499-505. PubMed ID: 8088918
[TBL] [Abstract][Full Text] [Related]
8. Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients.
Hirooka Y; Imaizumi T; Masaki H; Ando S; Harada S; Momohara M; Takeshita A
Hypertension; 1992 Aug; 20(2):175-80. PubMed ID: 1639458
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilation.
Kiowski W; van Brummelen P; Hulthén L; Amann FW; Bühler FR
Clin Pharmacol Ther; 1982 Jun; 31(6):677-84. PubMed ID: 7042175
[TBL] [Abstract][Full Text] [Related]
10. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
11. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
Stanek B; Silberbauer K
Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
[TBL] [Abstract][Full Text] [Related]
12. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension.
Johnston CI; Millar JA; McGrath BP; Matthews PG
Lancet; 1979 Sep; 2(8141):493-6. PubMed ID: 90216
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin system during converting enzyme inhibition with captopril in patients with severe treatment-resistant hypertension.
Rasmussen S; Damkjaer Nielsen M; Ibsen H; Leth A; Giese J
Eur J Clin Invest; 1984 Feb; 14(1):30-6. PubMed ID: 6321195
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients.
Fujita T; Ando K; Noda H; Sato Y; Yamashita N; Yamashita K
Am J Med; 1982 Sep; 73(3):341-7. PubMed ID: 6751080
[TBL] [Abstract][Full Text] [Related]
17. Peripheral hemodynamic effects of captopril in patients with congestive heart failure.
Nishimura H; Kubo S; Ueyama M; Kubota J; Kawamura K
Am Heart J; 1989 Jan; 117(1):100-5. PubMed ID: 2643280
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-I converting enzyme activity in the sera of captopril-treated hypertensive patients.
Rosenthal T; Holtzman E; Yaron A
Clin Exp Hypertens A; 1982; 4(3):367-77. PubMed ID: 6280902
[TBL] [Abstract][Full Text] [Related]
19. Chronic effects of direct vasodilation (pinacidil), alpha-adrenergic blockade (prazosin) and angiotensin-converting enzyme inhibition (captopril) in systemic hypertension.
Izzo JL; Licht MR; Smith RJ; Larrabee PS; Radke KJ; Kallay MC
Am J Cardiol; 1987 Aug; 60(4):303-8. PubMed ID: 2887102
[TBL] [Abstract][Full Text] [Related]
20. A comparison of angiotensin-converting enzyme inhibitors, calcium antagonists, beta-blockers and diuretic agents on reactive hyperemia in patients with essential hypertension: a multicenter study.
Higashi Y; Sasaki S; Nakagawa K; Ueda T; Yoshimizu A; Kurisu S; Matsuura H; Kajiyama G; Oshima T
J Am Coll Cardiol; 2000 Feb; 35(2):284-91. PubMed ID: 10676671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]